API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capmatinib-metastatic-non-small-cell-lung-cancer/
https://www.pharmatimes.com/news/novartis_lung_cancer_drug_tabrecta_gets_approval_1450335
https://seekingalpha.com/news/3825805-novartis-tabrecta-gets-ema-panel-backing-for-tabrecta-to-treat-lung-cancer-subtype
https://www.novartis.com/news/media-releases/novartis-announces-nejm-publication-pivotal-study-tabrecta-patients-metex14-metastatic-non-small-cell-lung-cancer#:~:text=Basel%2C%20September%202%2C%202020%20%E2%80%94,non%2Dsmall%20cell%20lung%20cancer%20(
https://pharmaphorum.com/news/fda-starts-quick-review-of-mercks-met-targeting-lung-cancer-drug/